Cbd Life Sciences

CBDL · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket open · · Delayed 15 min
Prev close $0.0002

Key indicators

CBDL profitability and balance sheet ratios

Net margin -4.1% in Jun 2022, up 150.1 points on a year earlier.

Net margin by quarter
PeriodNet margin
Mar 2021-91.6%
Jun 2021-154.3%
Mar 2022-6.0%
Jun 2022-4.1%

Income statement

No financial statements are reported for Cbd Life Sciences.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.